How Pfizer’s coronavirus vaccine breakthrough was achieved together with a previously obscure Mainz-based firm, BioNTech, which is now worth over a billion euros
Location / Corona UPDATE
How an international green energy company is pushing ahead with expansion into Germany and starting production of hydrogen electrolyzers
One of the clear winners of the coronavirus pandemic, which has seen people – voluntarily or not – spending unprecedented amounts of time at home, is the puzzle and games sector.
Thuringia stands out as a blockbuster investment location in Europe’s heartland, even in years as turbulent as 2020.
Pharmaceuticals colossus Bayer has partnered with German biotech company CureVac in the latter’s development of a vaccine to combat the coronavirus.
In a new survey, German digital industry association bitkom found that 79 percent of Germans regularly used cashless payment option in stores from September to November of last year.
Throughout 2020, this website featured more than 350 articles and videos about Germany as a business and high-tech location. Below is a list so that you can catch up on anything you might have missed.
One of the lessons we should learn for the post-corona era is that outbreaks of disease and even pandemics go hand in hand with increased destruction of nature.
The two leading German biotech companies producing vaccines against Covid-19 have both reached important milestones.
The world is waiting anxiously as the first coronavirus vaccines are being approved and tested for approval. But companies responsible for the logistics of getting those vaccines to people, once they are admitted for use, are already springing into action.